2025深圳国际高性能医疗器械展启幕

Core Viewpoint - The 2025 Shenzhen International High-Performance Medical Device and Innovative Pharmaceutical Exhibition aims to create an industry exchange platform, focusing on the theme of "Innovative Drugs and Devices, Collaborative Win-Win" to showcase cutting-edge achievements in the pharmaceutical and medical device industries and promote cooperation between Shenzhen and Hong Kong [1] Group 1: Exhibition Overview - The exhibition will take place in Hong Kong on December 11 and in Shenzhen from December 18 to 20, featuring a dual-city model [1] - The Hong Kong segment will focus on international clinical trials, technology and product exports, cell and gene therapy, AI in medical devices, and brain science [1] - The Shenzhen segment will cover the entire pharmaceutical and medical device supply chain, showcasing high-performance medical devices and innovative pharmaceuticals, including biomanufacturing, AI+healthcare, aesthetic devices, and home health [1] Group 2: Participation and Forums - The exhibition will feature over 300 participating companies and institutions, including global leaders like Siemens Healthineers, Medtronic, and Abbott, as well as domestic pioneers [2] - More than 20 high-level sub-forums will be held, addressing key topics such as policy interpretation, cutting-edge technology, clinical practice, market trends, and investment financing [2] - Notable experts and over 2,500 industry leaders will attend the opening ceremony and forums to share insights [2] Group 3: Highlights and Achievements - The exhibition will showcase five major highlights: high standards, broad fields, complete supply chains, new achievements, and a comprehensive ecosystem [3] - Significant technological advancements in Shenzhen's pharmaceutical and medical device sectors will be announced during the opening ceremony [3] - Shenzhen's medical device industry has been integrated into the "20+8" key industrial clusters, with a projected growth in output value from 128 billion to 157.6 billion yuan from 2020 to 2024, maintaining an annual growth rate of 5.3% [3]